Table 1.
Relationship between ER, ERmRNA expression and pathology in gastric cancer
| Pathology |
Male |
Female |
Total |
||||||||||||
| n | ER (+) | % | ERmRNA (+) | % | n | ER (+) | % | ERmRNA (+) | % | n | ER (+) | % | ERmRNA (+) | % | |
| Borrmann I | 3 | 1 | 33.3 | 1 | 33.3 | 3 | 0 | 0 | 2 | 66.7 | 6 | 1 | 16.7 | 3 | 50.0 |
| II | 4 | 1 | 25.0 | 3 | 75.0 | 4 | 2 | 50.0 | 3 | 75.0 | 8 | 3 | 37.5 | 6 | 75.0 |
| III | 4 | 1 | 25.0 | 3 | 75.0 | 4 | 2 | 50.0 | 4 | 100.0 | 8 | 3 | 37.5 | 7 | 87.5 |
| IV | 4 | 2 | 50.0 | 4 | 100.0 | 4 | 3 | 75.0 | 4 | 100.0 | 8 | 5 | 62.5 | 8 | 100.0 |
| Papillary | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 |
| Tubular | 6 | 0 | 0 | 4 | 66.7 | 6 | 1 | 16.7 | 5 | 88.3 | 12 | 1 | 8.3 | 10 | 83.3 |
| Poorly differentiated | 7 | 4 | 57.1 | 6 | 85.7 | 6 | 4 | 66.7 | 6 | 100.0 | 13 | 8 | 61.5 | 11 | 84.6 |
| Signet ring cell | 1 | 1 | 100.0 | 1 | 100.0 | 2 | 2 | 100.0 | 2 | 100.0 | 3 | 3 | 100.0 | 3 | 100.0 |
| Nondiffused | 9 | 2 | 22.2 | 6 | 66.7 | 5 | 1 | 20.0 | 4 | 80.0 | 14 | 3 | 21.4 | 10 | 71.4 |
| Diffused | 6 | 3 | 50.0 | 5 | 83.3 | 10 | 6 | 60.0 | 9 | 90.0 | 16 | 9 | 56.3 | 14 | 87.5 |
| Lymph node 0 | 3 | 0 | 0 | 1 | 33.3 | 4 | 0 | 0 | 3 | 75.0 | 7 | 0 | 0 | 4 | 57.1 |
| Involvemen ≤ 3 | 4 | 1 | 25.0 | 3 | 75.0 | 5 | 3 | 60.0 | 4 | 80.0 | 9 | 4 | 44.4 | 7 | 77.8 |
| 4~6 | 6 | 2 | 33.3 | 5 | 83.3 | 5 | 3 | 60.0 | 5 | 100.0 | 11 | 5 | 45.5 | 10 | 90.9 |
| > 6 | 2 | 2 | 100.0 | 2 | 100.0 | 1 | 1 | 100.0 | 1 | 100.0 | 3 | 3 | 100.0 | 3 | 100.0 |
| Age ≤ 55 | 6 | 3 | 50.0 | 4 | 66.7 | 9 | 3 | 33.3 | 7 | 77.8 | 15 | 6 | 40.0 | 11 | 73.3 |
| > 55 | 9 | 2 | 22.2 | 7 | 77.8 | 6 | 4 | 66.7 | 6 | 100.0 | 15 | 6 | 40.0 | 13 | 86.7 |
| Total | 15 | 5 | 33.3 | 11 | 73.3 | 15 | 7 | 46.7 | 13 | 86.7 | 30 | 12 | 40.0 | 24 | 80.0 |